Browse Category

HKG:1024 News 27 November 2025 - 16 January 2026

Hang Seng slips as tech drags again, while chip and AI names buck the trend in Hong Kong

Hang Seng slips as tech drags again, while chip and AI names buck the trend in Hong Kong

The Hang Seng Index closed down 0.29% in Hong Kong on Friday, pressured by losses in shipping, casino, and healthcare stocks. Ctrip shares plunged 19% the previous day after news of a China antitrust probe, rattling investors. Semiconductor stocks rose, with Hua Hong Semiconductor up 7.39%. Mainland investors sold about HK$600 million in Hong Kong shares via Stock Connect.
Top Hong Kong stocks today: Kuaishou surges, Alibaba climbs, CNOOC slides

Top Hong Kong stocks today: Kuaishou surges, Alibaba climbs, CNOOC slides

HONG KONG, Jan 5, 2026, 02:22 ET — Regular session Kuaishou Technology jumped 11.4% in afternoon trade, leading gains among Hang Seng blue chips as the benchmark index eased 0.06% to 26,321.87. Investors also pushed Innovent Biologics up 6.7% and Hansoh Pharma up 5.7%, while they sold oil producers CNOOC and PetroChina, down 3.5% and 3.2%, respectively. Turnover — the cash value of shares traded — clustered in exchange-traded funds (ETFs), with the Tracker Fund and the HSCEI ETF in the top five, alongside Alibaba, Tencent and SMIC. etnet 經濟通 That split tape matters now because traders keep treating Hong
Kuaishou Technology Class B Stock Today (HKEX: 1024): Price Action, Buyback Momentum and AI Growth – 27 November 2025

Kuaishou Technology Class B Stock Today (HKEX: 1024): Price Action, Buyback Momentum and AI Growth – 27 November 2025

Hong Kong – 27 November 2025 Kuaishou Technology Class B stock (KUAISHOU‑W, HKEX: 1024) traded slightly higher in Hong Kong on Thursday, as investors digested its strong third‑quarter results, a fresh share repurchase and ongoing optimism around its artificial intelligence (AI) strategy. 1. Kuaishou Technology Class B stock price today (27 November 2025) As of late morning in Hong Kong (around 11:59 a.m. HKT), Kuaishou Technology Class B was trading at HK$68.80, up 0.22% on the day, a gain of HK$0.15 from Wednesday’s close of HK$68.65. StockAnalysis Key intraday and valuation metrics today: At the open, Kuaishou mildly outperformed the

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
New York, Feb 7, 2026, 10:22 EST — Market closed. Eli Lilly and Company shares closed Friday up $37.34, or 3.7%, at $1,058.18. The move came as U.S. regulators sharpened their tone on “compounded” weight-loss drugs — pharmacy-made versions meant for shortages or special patient needs that have morphed into mass-market alternatives. The FDA said it would take action against telehealth firm Hims & Hers over a $49 pill it marketed as a Wegovy-like option, and Lilly said it “applauded” the agency’s action. (Reuters) Why it matters now: obesity and diabetes medicines have become the growth engine for large drugmakers,
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop